Abstract
To prevent or mitigate an AIDS epidemic among injecting drug users (IDUs), effective activities need to be implemented on a large enough scale to reach and assist sufficient numbers of drug users and thereby change their risk behaviors related to drug use and sex. Recent work by UNAIDS on "high coverage sites", adopting the above strategies, has shown that one of the key elements in achieving high coverage is ongoing and sophisticated advocacy. High coverage harm reduction sites were studied through literature search and site visits, including key informant interviews, review of service statistics, and data analysis, in order to document the steps that led to scaling up, the way coverage was defined in these sites, and the lessons learned from their efforts. Syringe-exchange programs can achieve high coverage of IDUs. Monitoring to determine regular reach (those who are in regular contact with harm reduction services) should be added to uniform data collection carried out by harm reduction programs. Advocacy is crucial to achieving high coverage.
References
Jan 1, 1968·Journal of the Chemical Society. Perkin Transactions 1·I E BurrowsD V Wilson
Mar 30, 2004·Journal of Urban Health : Bulletin of the New York Academy of Medicine·Don C Des JarlaisJudith Milliken
Dec 4, 2004·AIDS·Carmen AceijasUNKNOWN United Nations Reference Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries
Aug 13, 2005·Drug and Alcohol Review·David Al NewcombeRobert Ali
Citations
Dec 9, 2010·International Journal of Epidemiology·Wenyuan YinZunyou Wu
Jun 11, 2008·Harm Reduction Journal·Babak EshratiJohn Weekes
Dec 27, 2013·Harm Reduction Journal·Rahim Taghizadeh AslAli Mirzazadeh
Aug 4, 2011·AIDS and Behavior·Joanne BryantHannah Wilson
Feb 19, 2008·The International Journal on Drug Policy·Faran Emmanuel, Mehreen Fatima
Jan 22, 2008·The International Journal on Drug Policy·Catherine S ToddSteffanie A Strathdee
Aug 11, 2007·The International Journal on Drug Policy·Sheena G Sullivan, Zunyou Wu
Aug 11, 2007·The International Journal on Drug Policy·Mukta SharmaRicky Bluthenthal
Jul 13, 2007·Addiction·Richard Bedell
May 3, 2011·The International Journal on Drug Policy·Adnan A Khan, Ayesha Khan
Sep 10, 2014·PloS One·Lei LiJianhua Li
Aug 21, 2016·BMC Health Services Research·Daniel O'KeefePaul Dietze
Jan 30, 2014·Ciência & saúde coletiva·Aline Inglez-DiasKimberly Page
Feb 15, 2017·Harm Reduction Journal·Qing WuJan Hendrik Richardus
Jul 19, 2018·Ciência & saúde coletiva·Thaísa Borges Gomes, Marcelo Dalla Vecchia
Jun 21, 2017·Journal of Viral Hepatitis·D O'KeefeM Hellard